DON'T FALL FOR IT - 2021 E/M - Guidelines are a Trap

Why This Topic Matters

The topic affects how office/outpatient E/M services are documented, reviewed, and defended in audits after the 2021 rule changes. Readers who work with compliance, coding, or medical necessity determinations may want to understand the broader policy and audit concerns raised by the article.

Article Sections

1. The impact of the 2021 E/M changes

   Introduces the expected effects of the office/outpatient E/M documentation changes and the concern that payer review may respond to them. Discusses the broader operational and financial implications for providers and payers.

2. The future of non-clinical auditors

   Addresses how changes in documentation emphasis may affect the role of non-clinical auditors. Describes the general shift toward greater reliance on clinical judgment and medical necessity review.

3. Clinical judgment and medical necessity in payer review

   Summarizes the article’s discussion of clinical review judgment, medical necessity, and the relationship between payer policies and documentation review. References Medicare contractors and general policy sources.

4. Treating physician perspective and related case law

   Discusses legal and policy arguments the author associates with treating physician judgment, Medicare review, and federal case law. The section stays focused on the article’s general legal and administrative framing.

5. Current documentation elements and auditing concerns

   Reviews the traditional documentation components used in office visit auditing and the author’s concerns about cloning, carry-forward content, and documentation patterns. Also considers how these issues may remain relevant after the guideline changes.

6. Recommendations for practices

   Provides broad practice-oriented recommendations for maintaining thorough documentation and supporting the record. The guidance is framed around preparation for review, compliance, and audit readiness.

7. Why the changes may still be a trap

   Explains the author’s overall view that payer review and future policy clarification may limit the perceived simplicity of the new documentation approach. Ends with a discussion of continued audit risk and expectations for ongoing guidance.